A detailed history of Black Rock Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 24,157,768 shares of IRWD stock, worth $149 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,157,768
Previous 25,980,308 7.02%
Holding current value
$149 Million
Previous $297 Million 29.2%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$8.32 - $15.45 $15.2 Million - $28.2 Million
-1,822,540 Reduced 7.02%
24,157,768 $210 Million
Q4 2023

Feb 13, 2024

BUY
$8.79 - $11.51 $6.56 Million - $8.59 Million
746,046 Added 2.96%
25,980,308 $297 Million
Q3 2023

Nov 13, 2023

SELL
$8.25 - $11.35 $4.71 Million - $6.47 Million
-570,313 Reduced 2.21%
25,234,262 $243 Million
Q2 2023

Aug 11, 2023

BUY
$10.1 - $11.6 $4.92 Million - $5.65 Million
486,665 Added 1.92%
25,804,575 $275 Million
Q1 2023

May 12, 2023

SELL
$10.37 - $12.56 $4.72 Million - $5.72 Million
-455,471 Reduced 1.77%
25,317,910 $266 Million
Q4 2022

Feb 13, 2023

BUY
$9.9 - $12.43 $7.95 Million - $9.98 Million
803,283 Added 3.22%
25,773,381 $319 Million
Q3 2022

Nov 14, 2022

SELL
$10.14 - $12.38 $19.5 Million - $23.8 Million
-1,920,122 Reduced 7.14%
24,970,098 $259 Million
Q2 2022

Aug 12, 2022

BUY
$11.05 - $12.72 $137 Million - $157 Million
12,353,461 Added 84.98%
26,890,220 $310 Million
Q1 2022

May 12, 2022

BUY
$10.61 - $12.88 $1.78 Million - $2.16 Million
167,869 Added 1.17%
14,536,759 $183 Million
Q4 2021

Feb 10, 2022

BUY
$10.86 - $13.95 $20.6 Million - $26.5 Million
1,897,115 Added 15.21%
14,368,890 $168 Million
Q3 2021

Nov 09, 2021

BUY
$11.92 - $13.92 $11 Million - $12.8 Million
920,868 Added 7.97%
12,471,775 $163 Million
Q2 2021

Aug 11, 2021

BUY
$10.16 - $13.11 $117 Million - $151 Million
11,550,907 New
11,550,907 $149 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $945M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.